Characterizing Navigational Changes in Preclinical Alzheimer’s Disease: A Route Complexity Metric Derived From Naturalistic Driving Data

IF 3.9 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Kelly Long;Ganesh M. Babulal;Sayeh Bayat
{"title":"Characterizing Navigational Changes in Preclinical Alzheimer’s Disease: A Route Complexity Metric Derived From Naturalistic Driving Data","authors":"Kelly Long;Ganesh M. Babulal;Sayeh Bayat","doi":"10.1109/JTEHM.2025.3619802","DOIUrl":null,"url":null,"abstract":"Objective: To examine how early pathophysiological changes in Alzheimer’s disease (AD) affect navigational decision-making by analyzing the complexity of driving routes in older adults with and without preclinical AD. Methods: We developed a novel route complexity metric based on the number of left and right turns and the deviation from the most direct path, accounting for cognitive load during navigation. Naturalistic GPS driving data were collected for a year from 111 older adults aged 65–85, with preclinical AD status determined via cerebrospinal fluid amyloid biomarkers. A multiple linear regression model was used to assess the relationship between age, preclinical AD status, and route complexity. Results: The findings of this study indicate that preclinical AD may influence the navigational abilities of older adults. After controlling for age, participants with preclinical AD chose routes with higher baseline complexity than the control group. It further revealed that participants with preclinical AD selected routes with lower complexity as they aged—a trend not observed in healthy controls. Conclusion: Preclinical AD is associated with changes in spatial decision-making that are observable in real-world driving behaviours. The age-related decline in route complexity among those with preclinical AD may reflect compensatory strategies or progressive cognitive changes. Clinical Impact: This study presents a non-invasive, behaviour-based metric that could support early detection of cognitive decline. It may also inform the design of personalized mobility interventions and dementia-friendly mobility systems.","PeriodicalId":54255,"journal":{"name":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","volume":"13 ","pages":"471-479"},"PeriodicalIF":3.9000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=11197551","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","FirstCategoryId":"5","ListUrlMain":"https://ieeexplore.ieee.org/document/11197551/","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To examine how early pathophysiological changes in Alzheimer’s disease (AD) affect navigational decision-making by analyzing the complexity of driving routes in older adults with and without preclinical AD. Methods: We developed a novel route complexity metric based on the number of left and right turns and the deviation from the most direct path, accounting for cognitive load during navigation. Naturalistic GPS driving data were collected for a year from 111 older adults aged 65–85, with preclinical AD status determined via cerebrospinal fluid amyloid biomarkers. A multiple linear regression model was used to assess the relationship between age, preclinical AD status, and route complexity. Results: The findings of this study indicate that preclinical AD may influence the navigational abilities of older adults. After controlling for age, participants with preclinical AD chose routes with higher baseline complexity than the control group. It further revealed that participants with preclinical AD selected routes with lower complexity as they aged—a trend not observed in healthy controls. Conclusion: Preclinical AD is associated with changes in spatial decision-making that are observable in real-world driving behaviours. The age-related decline in route complexity among those with preclinical AD may reflect compensatory strategies or progressive cognitive changes. Clinical Impact: This study presents a non-invasive, behaviour-based metric that could support early detection of cognitive decline. It may also inform the design of personalized mobility interventions and dementia-friendly mobility systems.
表征临床前阿尔茨海默病的导航变化:来自自然驾驶数据的路线复杂性度量
目的:通过分析老年阿尔茨海默病(AD)患者和非老年阿尔茨海默病患者驾驶路线的复杂性,探讨老年阿尔茨海默病(AD)患者早期病理生理变化对导航决策的影响。方法:在考虑认知负荷的情况下,提出了一种基于左、右转弯次数和偏离最直接路径的路径复杂度度量方法。该研究收集了111名年龄在65-85岁之间的老年人一年的自然GPS驾驶数据,通过脑脊液淀粉样蛋白生物标志物确定其临床前AD状态。采用多元线性回归模型评估年龄、临床前AD状态和路径复杂性之间的关系。结果:本研究结果提示临床前AD可能影响老年人的导航能力。在控制了年龄后,临床前AD患者选择的路线比对照组具有更高的基线复杂性。它进一步揭示了临床前AD患者随着年龄的增长选择了复杂性较低的路线——这一趋势在健康对照组中没有观察到。结论:临床前AD与现实驾驶行为中可观察到的空间决策变化有关。在临床前AD患者中,与年龄相关的路径复杂性下降可能反映了代偿策略或进行性认知变化。临床影响:本研究提出了一种非侵入性的、基于行为的指标,可以支持早期发现认知能力下降。它还可以为个性化行动干预措施和痴呆症友好行动系统的设计提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.40
自引率
2.90%
发文量
65
审稿时长
27 weeks
期刊介绍: The IEEE Journal of Translational Engineering in Health and Medicine is an open access product that bridges the engineering and clinical worlds, focusing on detailed descriptions of advanced technical solutions to a clinical need along with clinical results and healthcare relevance. The journal provides a platform for state-of-the-art technology directions in the interdisciplinary field of biomedical engineering, embracing engineering, life sciences and medicine. A unique aspect of the journal is its ability to foster a collaboration between physicians and engineers for presenting broad and compelling real world technological and engineering solutions that can be implemented in the interest of improving quality of patient care and treatment outcomes, thereby reducing costs and improving efficiency. The journal provides an active forum for clinical research and relevant state-of the-art technology for members of all the IEEE societies that have an interest in biomedical engineering as well as reaching out directly to physicians and the medical community through the American Medical Association (AMA) and other clinical societies. The scope of the journal includes, but is not limited, to topics on: Medical devices, healthcare delivery systems, global healthcare initiatives, and ICT based services; Technological relevance to healthcare cost reduction; Technology affecting healthcare management, decision-making, and policy; Advanced technical work that is applied to solving specific clinical needs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书